Ontology highlight
ABSTRACT: Background
Gene therapy is currently in development for several monogenetic diseases including lysosomal storage disorders. Limited evidence is available on patient preferences for gene therapy in this population. In this study, we compare gene therapy-related risk tolerance between people affected by three lysosomal storage diseases currently faced with different therapeutic options and prognoses.Methods
A survey including the probabilistic threshold technique was developed in which respondents were asked to choose between gene therapy and the current standard of care. The attributes included to establish participants' risk tolerance were previously identified in focus groups of affected people or their representatives, namely: risk of mild side effects, severe side effect
SUBMITTER: Corazolla EM
PROVIDER: S-EPMC11451020 | biostudies-literature | 2024 Oct
REPOSITORIES: biostudies-literature